miRNA engineering of CHO cells facilitates production of difficult‐to‐express proteins and increases success in cell line development

In recent years, coherent with growing biologics portfolios also the number of complex and thus difficult‐to‐express (DTE) therapeutic proteins has increased considerably. DTE proteins challenge bioprocess development and can include various therapeutic protein formats such as monoclonal antibodies (mAbs), multi‐specific affinity scaffolds (e.g., bispecific antibodies), cytokines, or fusion proteins. Hence, the availability of robust and versatile Chinese hamster ovary (CHO) host cell factories is fundamental for high‐yielding bioprocesses. MicroRNAs (miRNAs) have emerged as potent cell engineering tools to improve process performance of CHO manufacturing cell lines. However, there has not been any report demonstrating the impact of beneficial miRNAs on industrial cell line development (CLD) yet. To address this question, we established novel CHO host cells constitutively expressing a pro‐productive miRNA: miR‐557. Novel host cells were tested in two independent CLD campaigns using two different mAb candidates including a normal as well as a DTE antibody. Presence of miR‐557 significantly enhanced each process step during CLD in a product independent manner. Stable expression of miR‐557 increased the probability to identify high‐producing cell clones. Furthermore, production cell lines derived from miR‐557 expressing host cells exhibited significantly increased final product yields in fed‐batch cultivation processes without compromising product quality. Strikingly, cells co‐expressing miR‐557 and a DTE antibody achieved a twofold increase in product titer compared to clones co‐expressing a negative control miRNA. Thus, host cell engineering using miRNAs represents a promising tool to overcome limitations in industrial CLD especially with regard to DTE proteins. Biotechnol. Bioeng. 2017;114: 1495–1510. © 2017 The Authors. Biotechnology and Bioengineering Published by Wiley Periodicals, Inc.

[1]  J. Shiloach,et al.  Stable inhibition of mmu-miR-466h-5p improves apoptosis resistance and protein production in CHO cells. , 2013, Metabolic engineering.

[2]  W. P. Loh,et al.  Overexpression of microRNAs enhances recombinant protein production in Chinese hamster ovary cells , 2014, Biotechnology journal.

[3]  Monilola A. Olayioye,et al.  Stable microRNA expression enhances therapeutic antibody productivity of Chinese hamster ovary cells. , 2013, Metabolic engineering.

[4]  Noelia Sanchez,et al.  MicroRNAs: tiny targets for engineering CHO cell phenotypes? , 2010, Biotechnology Letters.

[5]  S. Bahr,et al.  Profiling highly conserved microrna expression in recombinant IgG‐producing and parental Chinese hamster ovary cells , 2011, Biotechnology progress.

[6]  Vaibhav Jadhav,et al.  Dynamic mRNA and miRNA profiling of CHO‐K1 suspension cell cultures , 2012, Biotechnology journal.

[7]  Renate Kunert,et al.  Next-generation sequencing of the Chinese hamster ovary microRNA transcriptome: Identification, annotation and profiling of microRNAs as targets for cellular engineering , 2011, Journal of biotechnology.

[8]  Akhilesh Pandey,et al.  Gene Expression Profiling of Gastric Cancer , 2011, Journal of proteomics & bioinformatics.

[9]  Simon Fischer,et al.  Enhanced protein production by microRNA-30 family in CHO cells is mediated by the modulation of the ubiquitin pathway. , 2015, Journal of biotechnology.

[10]  A. Wagner,et al.  miR‐2861 as novel HDAC5 inhibitor in CHO cells enhances productivity while maintaining product quality , 2015, Biotechnology and bioengineering.

[11]  Vaibhav Jadhav,et al.  Annotation of additional evolutionary conserved microRNAs in CHO cells from updated genomic data , 2015, Biotechnology and bioengineering.

[12]  N. Borth,et al.  Noncoding RNAs, post-transcriptional RNA operons and Chinese hamster ovary cells , 2015 .

[13]  Vaibhav Jadhav,et al.  Stable overexpression of miR-17 enhances recombinant protein production of CHO cells☆ , 2014, Journal of biotechnology.

[14]  S. Kochanek,et al.  Temperature‐sensitive miR‐483 is a conserved regulator of recombinant protein and viral vector production in mammalian cells , 2016, Biotechnology and bioengineering.

[15]  Cao Huang,et al.  A tightly regulated Pol III promoter for synthesis of miRNA genes in tandem. , 2008, Biochimica et biophysica acta.

[16]  A. Wagner,et al.  A functional high-content miRNA screen identifies miR-30 family to boost recombinant protein production in CHO cells. , 2014, Biotechnology journal.

[17]  Liang Chen,et al.  Role of Deregulated microRNAs in Breast Cancer Progression Using FFPE Tissue , 2013, PloS one.

[18]  Vaibhav Jadhav,et al.  Computational identification of microRNA gene loci and precursor microRNA sequences in CHO cell lines , 2012, Journal of biotechnology.

[19]  Anushya Muruganujan,et al.  PANTHER version 11: expanded annotation data from Gene Ontology and Reactome pathways, and data analysis tool enhancements , 2016, Nucleic Acids Res..

[20]  W. Harris,et al.  Differential efficiency of expression of humanized antibodies in transient transfected mammalian cells. , 1998, Hybridoma.

[21]  R. Davis,et al.  The role of c-Jun N-terminal kinase (JNK) in apoptosis induced by ultraviolet C and gamma radiation. Duration of JNK activation may determine cell death and proliferation. , 1996, The Journal of biological chemistry.

[22]  P. Carter,et al.  Alternative molecular formats and therapeutic applications for bispecific antibodies. , 2015, Molecular immunology.

[23]  S. J. Wilkinson,et al.  Model‐directed engineering of “difficult‐to‐express” monoclonal antibody production by Chinese hamster ovary cells , 2014, Biotechnology and bioengineering.

[24]  C. Clarke,et al.  CHO cell culture longevity and recombinant protein yield are enhanced by depletion of miR-7 activity via sponge decoy vectors. , 2014, Biotechnology journal.

[25]  Daniel Seeliger,et al.  Boosting antibody developability through rational sequence optimization , 2015, mAbs.

[26]  Vaibhav Jadhav,et al.  A screening method to assess biological effects of microRNA overexpression in Chinese hamster ovary cells , 2012, Biotechnology and bioengineering.

[27]  S. Sharfstein,et al.  Identifying bottlenecks in transient and stable production of recombinant monoclonal‐antibody sequence variants in chinese hamster ovary cells , 2012, Biotechnology progress.

[28]  Simon Fischer,et al.  Unveiling the principle of microRNA-mediated redundancy in cellular pathway regulation , 2015, RNA biology.

[29]  A. Sczyrba,et al.  miRNA profiling of high, low and non-producing CHO cells during biphasic fed-batch cultivation reveals process relevant targets for host cell engineering. , 2016, Journal of biotechnology.

[30]  Ana Kozomara,et al.  miRBase: annotating high confidence microRNAs using deep sequencing data , 2013, Nucleic Acids Res..

[31]  Andreas Plückthun,et al.  Engineered proteins with desired specificity: DARPins, other alternative scaffolds and bispecific IgGs. , 2014, Current opinion in structural biology.

[32]  I. Grummt,et al.  The nucleolus as a stress sensor: JNK2 inactivates the transcription factor TIF-IA and down-regulates rRNA synthesis. , 2005, Genes & development.

[33]  C. Fux,et al.  Recombinant protein production by transient gene transfer into Mammalian cells. , 2009, Methods in enzymology.

[34]  C. Clarke,et al.  Engineering CHO cell growth and recombinant protein productivity by overexpression of miR-7. , 2011, Journal of biotechnology.

[35]  M. Fussenegger,et al.  Epigenetic Engineering of Ribosomal RNA Genes Enhances Protein Production , 2009, PloS one.

[36]  Hiroshi Tanaka,et al.  Identification of pathogenesis-related microRNAs in hepatocellular carcinoma by expression profiling. , 2012, Oncology letters.

[37]  F. Wurm,et al.  Disassembly of polyethylenimine-DNA particles in vitro: implications for polyethylenimine-mediated DNA delivery. , 2006, Journal of controlled release : official journal of the Controlled Release Society.

[38]  S. Estes,et al.  Integrated cell and process engineering for improved transient production of a “difficult‐to‐express“ fusion protein by CHO cells , 2015, Biotechnology and bioengineering.

[39]  David P. Kreil,et al.  CHO microRNA engineering is growing up: Recent successes and future challenges☆ , 2013, Biotechnology advances.

[40]  Simon Fischer,et al.  The art of CHO cell engineering: A comprehensive retrospect and future perspectives. , 2015, Biotechnology advances.

[41]  H. Katinger,et al.  MicroRNAs as targets for engineering of CHO cell factories. , 2008, Trends in biotechnology.

[42]  G. Blandino,et al.  Oncogenic MicroRNAs: Key Players in Malignant Transformation , 2015, Cancers.

[43]  Profiling conserved microRNA expression in recombinant CHO cell lines using Illumina sequencing. , 2012, Biotechnology and bioengineering.

[44]  C. Gallagher,et al.  Re-programming CHO cell metabolism using miR-23 tips the balance towards a highly productive phenotype. , 2015, Biotechnology journal.

[45]  Jamey D. Young,et al.  Peak antibody production is associated with increased oxidative metabolism in an industrially relevant fed‐batch CHO cell culture , 2013, Biotechnology and bioengineering.

[46]  N. Borth,et al.  miRNAs--pathway engineering of CHO cell factories that avoids translational burdening. , 2012, Trends in biotechnology.

[47]  A. Wagner,et al.  Breaking limitations of complex culture media: functional non-viral miRNA delivery into pharmaceutical production cell lines. , 2013, Journal of biotechnology.

[48]  S. Eberhardy,et al.  Iron (III) citrate inhibits polyethylenimine-mediated transient transfection of Chinese hamster ovary cells in serum-free medium , 2009, Cytotechnology.